Horizon/Amgen Patient Assistance Program

Manufacturer copay assistance · Krystexxa (J2507) · Horizon Therapeutics

Free · Maximum benefit No limit — free drug · Covers drug cost only — administration billed separately

OPEN
Status verified March 26, 2026 · Source: program site ↗

Program terms

Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.

Assistance type
Free Drug
Patient pays
Free
Maximum benefit
No limit — free drug
What it covers
Covers drug cost only — administration billed separately
Insurance
uninsured no medicare no commercial no medicaid
Processing time
2-4 weeks
Krystexxa costs ~$40,000/year. Reserved for severe, chronic, treatment-refractory gout in patients who have failed oral urate-lowering therapy. IV infusion administered in a healthcare facility. Now often co-administered with immunomodulator to reduce anti-drug antibodies.

Medicare or Medicaid patient?

This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.

Common questions

Does Krystexxa have a copay card?

Yes — Horizon/Amgen Patient Assistance Program from Horizon Therapeutics. Free. Commercial insurance is required; Medicare and Medicaid patients are not eligible.

How much does Krystexxa cost with the copay card?

Free Maximum benefit: No limit — free drug. Covers drug cost only — administration billed separately

Who is eligible for Horizon/Amgen Patient Assistance Program?

Accepted insurance: uninsured. Not eligible: medicare, commercial, medicaid.

Patient or caregiver? Your infusion center's financial counselor can enroll you — or call the program at 1-888-479-6667.